Pharmacological inhibition of PAD4 using the PAD4 isoform-selective small-molecule inhibitor JBI-589 (12) in LL2 tumor-bearing mice resulted in decreased CXCR2 expression and blocked neutrophil chemotaxis. The gene discussed is PADI4; the disease is neoplasm.